Conversely, only four of the thirteen deletions that resulted in a significant decrease in expression in tumors were previously identified as down-regulated when comparing normal and tumor tissue (CRYAB, SACS, HSPB7, and HSPB2). The gene discussed is HSPB2; the disease is neoplasm.